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1. Introduction 
Thyroid hormones have been found to influence 
several enzymatic activities [l-3]. Concerning lipid 
metabolism the hyperthyroid state is associated with 
increased oxidation of cholesterol [4] and fatty acids 
[S]. At the same time in these conditions an enhanced 
activity in acetate incorporation into lipids has been 
observed [6,7]. This rise in the liver is essentially due 
to a strong increase in both acetyl-CoA carboxylase 
and fatty acid synthetase activities [&-IO]. As for the 
latter system Roncari and Murthy [9], by using specific 
antibDdies, have proposed that the effect of Lthyroxine 
is mediated through an increase in enzyme level. 
Recently we have reported strong stimulation of 
rat liver microsomal chain elongation of fatty acids in 
addition to acetyl-CoA carboxylase and fatty acid 
synthetase in hyperthyroidism [ 111. The purpose of 
the present investigation was to determine the details 
of the hormonal effect at the molecular level in the 
microsomal system. Liver microsomal fatty acid chain 
elongation synthesis activity was therefore measured 
both in triiodothyronine and in triiodothyronine plus 
cycloheximide or actinomycin D-treated rats. Results 
obtained provide evidence for the involvement of the 
hormone in the stimulation of synthesis of microsomal 
enzymes responsible for fatty acid chain elongation. 
2. Materials and methods 
2.1. Animals 
Triiodothyronine (30 Irg/lOO g body wt/day), dis- 
Elsevier/North-Holland Biomedical Press 
solved in 0.9% NaCl-propyleneglycol (v/v),was injected 
intraperitoneally in male Wistar rats weighing 150-160 
g, maintained on standard diet. Cycloheximide or 
actinomycin D, dissolved in the same solvent, was 
injected i.p. alone or with triiodothyronine, at the 
dose of 20 pg and 10 c(g/lOO g body wt/day, respec- 
tively. Control rats received only 0.9% NaCl-pro- 
pyleneglycol (v/v). The animals were killed by decapi- 
tation 24 h after final administration. All rata were fed 
ad libitum. The weight of treated animals did not 
significant differ from that of controls throughout. 
2.2. Preparation of subcellular fractions 
The livers were immediately removed, minced in 
10 ml icecold 0.25 M sucrose/g tissue and homogenized 
by mean of a Potter-Elvehjem homogenizer with a 
teflon pestle. All the preparations were carried out at 
0°C. Microsomes and cell sap were prepared as in [ 111. 
Protein was determined by the biuret method [ 121. 
2.3. Incubation procedure 
The assay for chain elongation of fatty acids by 
rat liver microsomes was carried out at 37’C for 10 min 
under Nz with constant shaking. Substrate and 
cofactor concentration was as in [ 11 J. The reaction 
was started by adding the subcellular fraction after 
flushing the sealed incubation vessels with NZ for 
10 min. The incorporation of [ 1 ,3-‘4C]malonyl-CoA 
into fatty acids by crude liver cell sap was accom- 
plished as in [ Ill. (NH&S04 precipitated cell sap 
(40% saturation) was used for assaying acetyl-CoA 
carboxylase [ 131. 
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2.4. Radioactivity measurement 
At the end of the incubation time, the reaction 
was stopped, fatty acids extracted and their total 
radioactivity determined as in ] 111. 
3. Results and discussion 
The effect of hyperthyroidism on rat liver micro- 
somal fatty acid chain elongation synthesis has been 
studied ]I 13. Figure 1 shows that after 3 daily intra- 
peritoneal triiodothyronine administrations to normal 
rats, specific activity almost doubles, rising from 
0.32-0.65 nmol [ 1 ,3-14C]malonyl-CoA incorporated 
into fatty acids/min/mg protein and increasing by 
184% after 5 days of hormone administration. These 
results are si~i~can~y different from those recently 
- Triiodothyronine 
&__* Trii~thymnine plus 
Fig.1. Liver microsomal fatty acid chain elongation synthesis 
following cycloheximide or actinomycin D in hyperthyroid 
rats. All animals received triiodothyronine for the entire 
period. When indicated, cycioheximide or actinomycin D 
was adm~istered from the day 2 on. Rats were sacrificed at 
the times shown, i.e., 24 h after final administration. The 
verticle bars represent standard deviations. Microsomal 
protein, 0.45 mg. 
found [ 141, where in vitro observed only very low 
stimulation of microsomal fatty acid chain elongation 
activity by the thyroid hormone. It is worthwhile to 
underline that incubation conditions used were as 
much as possible under anaerobiosis in order to mini- 
mize microsomal desaturation and thus study only 
fatty acid chain elongation in the hyperthyroid state. 
Roncari and Murthy [9] have proposed that 
increased activity of soluble rat liver fatty acid syn- 
thetase in hyperthyroidism is essentially due to an 
increased level of enzyme protein. Tata [2] on the 
other hand has provided evidence that increased pro- 
tein synthesis following triiodothyronine administra- 
tion is preceeded by stimulation of RNA synthesis. 
Since actinomycin D and cycloheximide have been 
currently used as in vivo inhibitors of both RNA and 
protein synthesis [15-l S], to clarify the mechanism 
of microsomal fatty acid chain elongation stimula- 
tion by thyroid hormones either of these antibiotics 
in addition to the hormone was injected for 3 days 
to rats to which only triiodothyronine had been 
previously administered for 2 days. The results of 
fig.1 show that already after 1 day of an~biotic 
administration, the increase of [l ,3-r4C]malonyf-CoA 
incorporation into fatty acids due to the hormone 
was strongly reduced, especially in the case of 
cycloheximide. In any case, either with cyclo- 
heximide or actinomycin D, the triiodothyronine- 
mediated stimulation of microsomal fatty acid 
chain elongation activity is almost completely 
abolished after 2 days antibiotic administration. 
It must be specified that some experiments (data 
not shown), in which only cycloheximide or actino- 
mycin D was given to rats at the same dose as in 
conjuction with triiodothyronine, indicated an 
activity of microsomal chain elongation after 1 day 
administration about 52% less than in untreated 
animals. In contrast, it is worth pointing out that 
when the antibiotic was administered together with 
triiodothyronine [ 1 ,3-14C]m~onyI-CoA ineorpora- 
tion still showed values slightly higher than that for 
control rats (cf. fig. I). The reduction of triiodo- 
thyronine-induced increase in microsomal fatty acid 
chain elongation activity consequent to antibiotic 
administration could thus be ascribed to its antago- 
nizing effect on protein synthesis as a consequence 
of inhibition of RNA synthesis. These results are in 
line with [2,16] where triiodothyronine-stimulation 
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Table 1 
Effect of cycloheximide or actinomycin D on liver acetylCoA carboxylase 
in triiodothyronine-treated rats 
Rats Spec. act. 
(nmol [ l-‘4C]malonyl-CoA 
formed/min/mg protein) 
Relative 
spec. act. 
(%) 
Control 
Triiodothyronine- 
treated 
Triiodothyronine- 
treated + cycloheximide 
Triiodothyronine- 
treated + actinomycin D 
1.35 * 0.18 100 
5.46 f 0.46 405 
1.68 + 0.15 125 
1.05 f 0.09 78 
Data : the mean value + SD of 3 pairs of livers pooled each. Triiodothyronine was 
injected intraperitoneally for 5 days. Cycloheximide or actinomycin D was 
administered in conjunction with triiodothyronine for 3 days to the animals 
which had previously received only triiodothyronine for 2 days. (NH&SO, 
precipitated cell sap protein (40% saturation) was used as enzyme source. Pro- 
tein, 0.23 mg 
of RNA synthesis in thyroidectomized rats was 
reduced by actinomycin D, giving the antibiotic at 
the dose of 8 pg/lOO g body wt, an amount similar 
to that we used in our experiments. 
Table 1 shows the activity of rat liver acetyl-CoA 
carboxylase (EC 6.4.1.2) in hyperthyroid rats and 
following antibiotic administration. As is evident 
from this table a strong stimulation (305%) of the 
specific activity of acetyl-CoA carboxylase can be 
observed in rats to which triiodothyronine was 
administered. This stimulation almost disappears 
when cycloheximide or actinomycin D was injected 
in addition to the hormone. The same behaviour is 
shown by soluble fatty acid synthetase from rat liver. 
In fact from table 2 it appears that de novo fatty 
acid synthesis from [ 1 ,3-r4C]malonyl-CoA by cell 
Table 2 
Effect of cycloheximide or actinomycin D on liver fatty acid synthetase in 
triiodothyronine-treated rats 
Rats Spec. act. 
(nmol [ 1,3-‘%]malonyl-CoA 
incorporated into 
fatty acids/min/mg protein) 
Relative 
spec. act. 
(%) 
Control 
Triiodothyronine- 
treated 
Triiodothyronine- 
treated + cycloheximide 
Triiodothyronine- 
treated + actinomycin D 
0.45 * 0.03 100 
1.49 * 0.18 331 
0.46 + 0.05 102 
0.37 + 0.04 82 
Data the mean value f SD of 3 pairs of livers pooled each. Triiodothyronine, 
cycloheximide and actinomycin D were administered as indicated in table 1. 
Crude cell sap protein, 0.35 mg 
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sap is greatly increased (23 1%) in the hyperthyroid 
state. The administration of cycloheximide or 
actinomycin D associated with triiodothyronine 
strongly reduces the stimulated incorporation of the 
labelled precursor due to the hormone. 
The observed increase in both acetyl-CoA carbox- 
ylase and fatty acid synthetase activities displayed 
in the hyperthyroid state is in agreement with 
[g-lo]. Reduced stimulation in the presence of 
cycloheximide or actinomycin D strongly supports 
the hypothesis that hyperthyroidism is responsible 
for a higher amount of these hepatic lipogenic 
enzymes [ lo] analogously to gluconeogenic ones 
[ 19,201. Moreover similarities in the behaviour of 
acetyl-CoA carboxylase, fatty acid synthetase and 
microsomal fatty acid chain elongation system to 
hormone administration suggest hat these may be 
linked as a unit by a common control mechanism. 
The fact that the induction of the enzyme syn- 
thesis responsible for the microsomal fatty acid 
chain elongation system observed in triiodothyro- 
nine-treated animals is clearly antagonized by cyclo- 
heximide or actinomycin D, well-known inhibitors 
of protein synthesis, suggests that, analogously to 
acetyl-CoA carboxylase and fatty acid synthetase 
[g-lo], increased microsomal fatty acid synthesis in 
this state is probably due to an increase in de novo 
enzymic protein synthesis and not to activation of 
preexisting enzymes. Lastly we wish to note that 
the present data well agree with the proposals 
[ 21,221 where, in the hyperthyroid state, a higher 
glycerophosphate acylating enzyme level occurs both 
in liver and heart. Then in this condition a larger 
amount of saturated and unsaturated long chain fatty 
acids would be available in microsomes for the 
enhanced esterifying activity. 
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